| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |